92 related articles for article (PubMed ID: 27013018)
1. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
[TBL] [Abstract][Full Text] [Related]
2. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
[TBL] [Abstract][Full Text] [Related]
3. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
Yamazaki Y; Nakamura Y; Omata K; Ise K; Tezuka Y; Ono Y; Morimoto R; Nozawa Y; Gomez-Sanchez CE; Tomlins SA; Rainey WE; Ito S; Satoh F; Sasano H
J Clin Endocrinol Metab; 2017 Apr; 102(4):1182-1192. PubMed ID: 28388725
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.
Wu VC; Huang KH; Peng KY; Tsai YC; Wu CH; Wang SM; Yang SY; Lin LY; Chang CC; Lin YH; Lin SL; Chu TS; Wu KD
Sci Rep; 2015 Jun; 5():11396. PubMed ID: 26066391
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
[TBL] [Abstract][Full Text] [Related]
6. 18-Oxocortisol: A journey.
Gomez-Sanchez CE; Gomez-Sanchez EP
J Steroid Biochem Mol Biol; 2023 Jun; 230():106291. PubMed ID: 36921907
[TBL] [Abstract][Full Text] [Related]
7. Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.
Rege J; Bandulik S; Nanba K; Kosmann C; Blinder AR; Plain A; Vats P; Kumar-Sinha C; Lerario AM; Else T; Yamazaki Y; Satoh F; Sasano H; Giordano TJ; Williams TA; Reincke M; Turcu AF; Udager AM; Warth R; Rainey WE
Nat Genet; 2023 Oct; 55(10):1623-1631. PubMed ID: 37709865
[TBL] [Abstract][Full Text] [Related]
8. Isradipine therapy in Cacna1dIle772Met/+ mice ameliorates primary aldosteronism and neurologic abnormalities.
Stölting G; Dinh HA; Volkert M; Hellmig N; Schewe J; Hennicke L; Seidel E; Oberacher H; Zhang J; Lifton RP; Urban I; Long M; Rivalan M; Nottoli T; Scholl UI
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37698934
[TBL] [Abstract][Full Text] [Related]
9. KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
Eur J Endocrinol; 2024 May; ():. PubMed ID: 38781451
[No Abstract] [Full Text] [Related]
10. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations.
Berthon A; Drelon C; Val P
N Engl J Med; 2016 Apr; 374(15):1493-4. PubMed ID: 27074082
[No Abstract] [Full Text] [Related]
12. Genetics of primary hyperaldosteronism.
Dutta RK; Söderkvist P; Gimm O
Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
[TBL] [Abstract][Full Text] [Related]
13. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
14. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.
Tauber P; Aichinger B; Christ C; Stindl J; Rhayem Y; Beuschlein F; Warth R; Bandulik S
Endocrinology; 2016 Jun; 157(6):2489-99. PubMed ID: 27035656
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of the
Hardege I; Long L; Al Maskari R; Figg N; O'Shaughnessy KM
Clin Sci (Lond); 2018 Jan; 132(1):145-156. PubMed ID: 29222092
[TBL] [Abstract][Full Text] [Related]
16. ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II).
De Sousa SMC; Stowasser M; Feng J; Schreiber AW; Wang P; Hahn CN; Gordon RD; Torpy DJ; Scott HS; Gagliardi L
J Hum Hypertens; 2017 Dec; 31(12):857-859. PubMed ID: 29022889
[No Abstract] [Full Text] [Related]
17. Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.
Buonacera A; Stancanelli B; Malatino L
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):217-229. PubMed ID: 28405904
[TBL] [Abstract][Full Text] [Related]
18. Genetic disorders in primary aldosteronism-familial and somatic.
Funder JW
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
